CATL’s 6.7 per cent discount to its Shenzhen-traded shares is much lower than the average 25 per cent discount for ...

Pfizer and RemeGen's HER2 antibody-drug conjugate delivered positive phase 3 results in a bladder cancer trial in China. | ...

Tesla faces falling global demand, rising competition, and margin pressure, undermining its long-term outlook/valuation.

Chinese restaurant operator Green Tea Group Limited, backed by Swiss private equity (PE) firm Partners Group, marked its debut on the main board of the Hong Kong stock exchange on Friday following its ...

Chinese AI drug developer METiS Pharmaceuticals is preparing for a Hong Kong initial public offering that could raise up to $200 million, highlighting the ongoing surge of investment in artificial ...

The China-based casual dining brand began trading its IPO after pricing its 168,364,000 shares at HKD 7.19 per share.

From tokenisation and digital assets to AI-first banking, Dubai is rewriting the rules of finance. With a bold regulatory ...

Minority owner Partners Group say the IPO proceeds will be used to further grow the Hangzhou-headquartered restaurant's ...

Chinese biotech company Bliss Biopharmaceutical (BlissBio) is reportedly considering a Hong Kong initial public offering (IPO ...

China's market was characterized by an intense wave of positive factors, UBS Global Banking said. Despite the certain ...

Auntea Jenny is the latest of a string of tea companies to list in Hong Kong, just this year. Emily Tan takes a closer look at that market action.

Shares of the restaurant chain began trading at HK$7.19 per share, unchanged from the offer price, before plunging 7 per cent ...